Arvinas, Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
5
Bearish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
ARVN
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ currently unprofitable (-31% margin).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
HOLD
Target $14.88 (+41.5%)
16 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
ARVN
UNH
—
Trailing P/E
27.9×
-3.0×
Forward P/E
17.8×
-30.8%
Profit Margin
2.7%
100.0%
Gross Margin
18.8%
-16.2%
ROE
12.2%
-84.0%
Revenue Growth
2.0%
—
Earnings Growth
0.7%
1.98
Beta
0.41
—
Price / Book
—
$672M
Market Cap
$334.9B
$6 – $15
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →